找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cell Penetrating Peptides; Methods and Protocol ülo Langel Book 2022Latest edition The Editor(s) (if applicable) and The Author(s), under e

[復(fù)制鏈接]
樓主: 小巷
51#
發(fā)表于 2025-3-30 08:16:13 | 只看該作者
52#
發(fā)表于 2025-3-30 15:05:31 | 只看該作者
53#
發(fā)表于 2025-3-30 20:24:54 | 只看該作者
In Silico Design of Chemically Modified Cell-Penetrating Peptidesng drug delivery vehicles. Numerous in silico tools have been developed over the years to design and predict the cell-penetrating peptides that contain natural amino acids. The majority of natural cell-penetrating peptides have several limitations including stability, immunogenicity as well as got e
54#
發(fā)表于 2025-3-30 21:46:32 | 只看該作者
55#
發(fā)表于 2025-3-31 04:51:26 | 只看該作者
A Native CPP from Rattlesnake with Therapeutic and Theranostic Propertiestides can rely on a high content of positive charges, as it is the case of the native CPP crotamine. Crotamine is a polypeptide of about 42 amino acid residues with high content of basic residues as Arg and Lys. Although most of known CPPs are linear peptides,?native crotamine from the venom of a So
56#
發(fā)表于 2025-3-31 08:54:56 | 只看該作者
57#
發(fā)表于 2025-3-31 09:42:27 | 只看該作者
Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology EVs are able to transfer their contents (including nucleic acids, proteins, lipids, and small molecules) to recipient cells, and thus hold great promise as drug delivery vehicles. However, their therapeutic application is limited by lack of efficient cargo loading strategies, a need to improve EV t
58#
發(fā)表于 2025-3-31 15:10:04 | 只看該作者
59#
發(fā)表于 2025-3-31 17:48:26 | 只看該作者
Membrane Molecular Interactions and Induced Structures of CPPsal properties, they are classified as three main groups, namely hydrophobic, amphipathic, and hydrophilic. They are capable of interacting with the cell membrane without inducing serious toxicity, and they can carry cargo molecules across the membrane. Cargo molecules could be different therapeutics
60#
發(fā)表于 2025-4-1 00:23:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-29 14:21
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
万山特区| 英山县| 许昌市| 漳平市| 油尖旺区| 关岭| 上蔡县| 枣强县| 兰溪市| 柞水县| 嘉定区| 玉林市| 和田县| 阜阳市| 巴马| 昌吉市| 枣阳市| 通江县| 伊宁市| 武山县| 壶关县| 仙游县| 灵山县| 嘉祥县| 鲁甸县| 奉贤区| 临邑县| 寿光市| 林西县| 怀仁县| 怀柔区| 巍山| 乌兰县| 石柱| 高陵县| 清远市| 剑川县| 崇左市| 韶山市| 亳州市| 四子王旗|